FEATURED NEWS

222. How much has been spent on Covid-19 anti-virals?

Question Number: 322
PDR Number: SQ22-000699
Date Submitted: 21/11/2022
Department or Body: Department of Health

To 31 October 2022, $331 million has been spent on COVID-19 oral antiviral treatments, Lagevrio® (molnupiravir) and Paxlovid® (nirmatrelvir and ritonavir). Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Benefits Scheme data sourced from: http://medicarestatistics.humanservices.gov.au/statistics/pbs_item.jsp.

Share:

Facebook
Twitter
Pinterest
LinkedIn

SENATE SPEECHES

THE ISSUES

Click on an interest area to read articles and learn more about the work I am doing in Parliament.

Taxation, Finance & Economy

READ MORE

Education & Family

READ MORE

Energy

READ MORE

Environment

READ MORE

Health, Aged Care & Seniors

READ MORE

Primary Industries

READ MORE

Immigration & Foreign Affairs

READ MORE

Infrastructure, Manufacturing, Transport & Tourism

READ MORE

Defence

READ MORE

Federation Reform

READ MORE

I may get kicked off social media soon for speaking too much truth so please join my mailing list so we can always stay in touch...

Thank you,

Gerard